These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12814776)

  • 1. The quest for a vaccine against Helicobacter pylori: how to move from mouse to man?
    Ruggiero P; Peppoloni S; Rappuoli R; Del Giudice G
    Microbes Infect; 2003 Jul; 5(8):749-56. PubMed ID: 12814776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental model of Helicobacter pylori infection.
    Del Giudice G; Ghiara P; Rappuoli R
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S261-3. PubMed ID: 10077750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in vaccination against Helicobacter pylori.
    Velin D; Michetti P
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):157-66. PubMed ID: 20350263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori vaccine development: facing the challenge.
    Aebischer T; Schmitt A; Walduck AK; Meyer TF
    Int J Med Microbiol; 2005 Sep; 295(5):343-53. PubMed ID: 16173501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice.
    Li HB; Zhang JY; He YF; Chen L; Li B; Liu KY; Yang WC; Zhao Z; Zou QM; Wu C
    Vaccine; 2012 Dec; 31(1):120-6. PubMed ID: 23137845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
    Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against Helicobacter pylori--an old companion of man.
    Keller WC; Michetti P
    Expert Opin Biol Ther; 2001 Sep; 1(5):795-802. PubMed ID: 11728215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
    Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
    Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines: an ongoing promise?
    Alsahli M; Farrell RJ; Michetti P
    Dig Dis; 2001; 19(2):148-57. PubMed ID: 11549825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model.
    Hoffelner H; Rieder G; Haas R
    Int J Med Microbiol; 2008 Jan; 298(1-2):151-9. PubMed ID: 17714988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection.
    Aebischer T; Walduck A; Schroeder J; Wehrens A; Chijioke O; Schreiber S; Meyer TF
    Int J Med Microbiol; 2008 Jan; 298(1-2):161-8. PubMed ID: 17702653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination.
    Prinz C; Hafsi N; Voland P
    Trends Microbiol; 2003 Mar; 11(3):134-8. PubMed ID: 12648945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How far are we from vaccination against Helicobacter pylori infection?
    Stubljar D; Jukic T; Ihan A
    Expert Rev Vaccines; 2018 Oct; 17(10):935-945. PubMed ID: 30238819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for the development of a vaccine against Helicobacter pylori.
    Telford JL; Ghiara P
    Drugs; 1996 Dec; 52(6):799-804. PubMed ID: 8957151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
    Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
    Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current status of Helicobacter pylori vaccines: a review.
    Kabir S
    Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.
    Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK
    Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards the development of vaccines against Helicobacter pylori: status and issues.
    Del Giudice G
    Curr Opin Investig Drugs; 2001 Jan; 2(1):40-4. PubMed ID: 11527009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens.
    Keenan JI; Rijpkema SG; Durrani Z; Roake JA
    FEMS Immunol Med Microbiol; 2003 May; 36(3):199-205. PubMed ID: 12738392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.